SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0221
SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0222
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Neutralization
Human
IgG1, kappa
CC40.8
SARS-CoV-2
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
BD55-5514
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
COV44-62
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
P2B-2F6
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, lambda2
E. coli
P0DTD1
Asp4891-Val5212
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
E. coli
P0DTC2 & P0DTC4 & P0DTC5
RBD [Arg319-Phe541] & E [Arg38-Val75] & M [Arg101-Gln222]
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Plasma, Serum
9.13 pg/mL
15.63 - 1, 000 pg/mL